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SUMMARY. Triploidy means that there is a complete extra set of chromosomes in every cell of affected fetus. Instead of
having 46 chromosomes, one set of 23 chromosomes from each parent, an individual with triploidy has 69 chromosomes.
Triploidy can be detected prenatally by cytogenetic analysis of fetal cells obtained by chorionic villous sampling (CVS)
or by amniocentesis. Postnatal diagnosis is based on phenotype of the proband with cytogenetic confirmation by
karyotyping. Triploidy is lethal, most fetuses are miscarried, while some die within a few hours or days after birth. Turner
syndrome is a form of primary ovarian insufficiency, called also gonadal disgenesis. Both, triploidy and Turner syndrome
should be taken into consideration if sonography reveals minor or major abnormalities of the fetus in the first or in the
second trimester of pregnancy. Active screening of these conditions is not justified in the general population. In rare
occasions, both conditions can be diagnosed prenatally by ultrasound. The aim of this paper is to underline the importance
of accurate prenatal ultrasonic diagnosis in everyday professional work, even though the conditions which are searched
for are rare and exotic.
Pregled
Klju~ne rije~i: ultrazvuk, prenatalna dijagnoza, triploidija, Turnerov sindrom
SA`ETAK. Triploidija ozna~ava postojanje jo{ jednog kompleta kromosoma u svakoj stanici oboljeloga ploda. Umjesto
46 kromosoma odnosno jednog kompleta po 23 kromosoma od svakog roditelja, jedinka s triploidijom ima 69 kromoso-
ma. Triploidija se mo`e otkriti prenatalno citogenetskom analizom stanica ploda dobivenih biopsijom korionskih resica
ili amniocentezom. Postnatalna dijagnoza se zasniva na fenotipu probanda uz citogenetsku potvrdu odre|ivanjem karioti-
pa. Triploidija je letalna, ve}ina se plodova spontano pobaci, dok ostali umiru tijekom prvih nekoliko sati ili dana po
ro|enju. Turnerov sindrom je oblik primarne insuficijencije jajnika koji se naziva i gonadalna disgeneza. Na postojanje
bilo triploidije bilo Turnerova sindroma valja posumnjati ako se ultrazvukom u ploda otkriju male ili velike malformacije
tijekom prvoga ili drugog tromjese~ja trudno}e. Aktivni probir ovih stanja nije opravdan u op}oj populaciji. Rijetko se i
jedna i druga bolest mogu dijagnosticirati prenatalno ultrazvukom. Cilj ovoga ~lanka je ukazati na va`nost pravilne
prenatalne ultrazvu~ne dijagnoze u svakodnevnom radu ~ak i u slu~ajevima kad su bolesti za kojima se traga rijetke i
egzoti~ne.
Introduction
Turner syndrome (Ullrich-Turner) is a genetic disor-
der characterized by low stature, with exclusively femi-
nine phenotype and gonadal dysgenesis (gonadal streaks)
in over 90% of the cases. Triploidy is a chromosomal
abnormality where three instead of two haploid sets of
chromosomes are present. In other words, in humans
there are 69 instead of 46 chromosomes. Triploidy is a
rare syndrome estimated to occur in about 2% of con-
ceptuses.1 Prevalence of Turner syndrome is about
1/1200 at 12 weeks and less than 1/4000 at 40 weeks of
gestation. Prevalence of triploidy is 1/2000 at 12 weeks,
and very rare at term.
Clinical features in Turner syndrome are due to defect
of the sexual X chromosome which can be absent in all
cells of the respective organism, or only some cells are
affected, while the others are normal. The classical ka-
ryotype is aneuploid 45,XO, but it can also be a mo-
saicism: 45,XO/46,XX; 45,XO/47,XXX; 45,XO/46,XX/
47,XXX (Turner like gonadal dysgenesis – with posi-
tive sex chromatin); or 45,XO/46,XY; 45,XO/47,XYY;
45,XO/46,XY/47,XYY mosaicism (Turner like gonadal
dysgenesis – with negative sex chromatin and very often
with deletion of the SRY gene of the testicular determi-
nation factor from Y chromosome). Besides, any struc-
tural defect of the X chromosome like 46,XXqi and
45,XO/46,XXqi; 46,XXr and 45,XO/46,XXr; 46,XXp
and 45,XO/46,XXp; 46,XXq and 45,XO/ 46,XXq, X
isodicentric, translocation X – autosome or even iso-
chromosome for the short arm of the X chromosome Xpi
may result in Turner fenotype. The classical karyotype
is detected in approximately 60% of the patients and it
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the syndrome.2 The percentage of probands with mo-
saicism depends on the methods used in genetic analy-
sis. Sometimes, rarely in the cases with 45,XO ka-
ryotype, more frequently in the cases with partial dele-
tions of X chromosome, the non-degenerated ovarian
follicles persist until puberty and determine the partial
onset of the secondary sexual characteristics.
The incidence of X chromosome defects is estimated
to be 1:2,000–2,500 of live births; more recently con-
trolled studies revealed incidence of about 1:5,000–
6,000 of the female live births.3
Monosomy of the X chromosome is probably the
most frequent genetic abnormality in human species,
but it is accompanied by very high embryo-fetal letha-
lity. The incidence of 45,XO zygotes is almost 2%, but
less than 1% of them survive till term; 7 to 15% of all the
spontaneous abortions have 45,XO karyotype. The pro-
ducts of conception with mosaicism or with structural
defects of X chromosome survive more frequently than
those with 45,XO karyotype.
About 50% of patients apparently have the full mo-
nosomy 45,XO while the rest of them have mosaicism.
In about 2/3 of patients maternal X is present, while 1/3
of them have the paternal X. Advanced maternal age is
not a risk factor in this syndrome. Only one X is normal
and functioning; the other X is not present at all, or only
a part of the chromosome is missing due to the structural
abnormality, deletion or translocation. Mosaicism
45,XO/46,XX or 45,XO/46,XX/47,XXX may also be
present. In 10% of Turner mosaics Y chromosome is
present (45,XO/46,XY), which increases the risk of go-
nadoblastoma.4 These patients may require a prophylac-
tic gonadectomy to prevent death from malignancy.
The most frequent karyotype in triploidy is 69,XXY,
while other karyotypes like 69,XXX are present in 60%
to 37%, and 69,XYY in only 3%. Triploidy is known
as probably the most frequent human genetic defect. It
is estimated that over 25% of genetic abortions are be-
ing triploid. There is no correlation with maternal age.
The incidence of liveborn triploid newborn is about
1/50000.5
Prenatal diagnosis
The main screening methods of prenatal diagnosis are
ultrasound and serological tests, which are also used in
prenatal screening of Turner syndrome and triploidy.
The diagnosis is confirmed by amniocentesis or chori-
onic villi sampling in order to determine karyotype in fe-
tuses with high risk for chromosomopathies. Spencer et
al.6 in one of their studies stated that a large proportion
of triploidy cases of both phenotypes could be identified
in the first trimester using nuchal translucency (NT),
maternal serum free beta-hCG and PAPP-A while in-
vestigating the risk for trisomy 21.
Echographic Screening
The »first trimester« ultrasound (11 – 14 weeks)
Ultrasound examination in this period is not specific
for Turner syndrome and triploidy, while it detects only
signs indicating possibility of any aneuploidy. The ul-
trasound in Turner syndrome at the end of the first tri-
mester of gestation detects increased nuchal translu-
cency (Figure 1), fetal tachycardia and early intrauterine
growth restriction.7
Increased NT is the most important echographic sign
for all chromosomal abnormalities, between 10 and 14
weeks of gestation. The cut-off value for establishing
the pathological NT is in general about 3 mm.
Increased NT in Turner syndrome is observed in 85%
of fetuses, while moderate intrauterine growth restric-
tion and tachycardia are observed in 50% of cases.7 In-
creased NT appears in 60% of triploidy cases. Early and
assimetric growth restriction, bradycardia, holoprosen-
cephaly, exomphalos, cyst of the posterior fossa, cere-
bral anomalies, abdominal wall defects are found in
40% of fetuses, while in 30% of them molar changes in
the placenta are present.8 Cardiac anomalies seem to be
the most important major structural abnormalities
linked to increased NT, with the exponential raising of
Table 1. The incidence of chromosomal abnormalities in early spontane-
ous abortion (adapted from reference
5
)
Tablica 1. U~estalost kromosomskih anomalija u plodova nakon ranog
spontanog poba~aja (prilago|eno prema referenci
5
)
Chromosomal anomaly Incidence (%)
Turner syndrome, 45,X0 – Turnerov sindrom 18
Triploidy – Triploidija 17
Trisomy 16 – Trisomija 16 16
Other polyploidies – Ostale poliploidije 6.1
Trisomy 22 – Trisomija 22 5.7
Trisomy 21 – Trisomija 21 4.7
Trisomy 15 – Trisomija 15 4.2
Trisomy 14 – Trisomija 14 3.7
Trisomy 13 – Trisomija 13 3.5
Trisomy 18 – Trisomija 18 3.1
Other trisomies – Ostale trisomije 14
Figure 1. Increased nuchal translucency at 12 weeks of gestation
Slika 1. Pove}ana nuhalna prozra~nost u ploda od 12 tjedana
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their prevalence if the NT increases over 3,5 mm.9,10 Al-
though increased NT has been described occasionaly in
all major cardiac defects, it is strongly associated with
anomalies of the left heart such as the left ventricular
hypoplasia or coarctation of the aorta. When narrowing
of the aortic istmus is present and associated with wide
ascending aorta (trisomies-18 or -21), nuchal edema can
be explained by insufficient blood flow in the region
perfused by ascending aorta. In the Turner syndrome the
narrowing of entire aortic arch is present and the in-
creased NT cannot be explained by the above mentioned
mechanism. Increasing NT in fetuses with Turner syn-
drome is explained by the defect in the formation of the
lymphatic vessels in the region of the thorax and the
neck, caused by the insufficiency of the lymphogenic
genes in the monosomy X, which determines develop-
ment of nuchal edema. The primary defect of the forma-
tion of the lymphatic vessels is included in a larger phe-
nomenon of abnormalities of the cellular migration in
embryogenesis. Figure 2 is showing 3D view of the
cystic hygroma in a fetus of 12 weeks.
In the second trimester nuchal edema presenting as
cystic hygroma with septa is most frequently associated
with Turner syndrome, while the first trimester increa-
sed NT is most frequently associated with trisomy-21.
In a large controlled study, nuchal translucency over 5
mm was associated with a 28 times increase in the inci-
dence of Down syndrome and only 9 times increase in
the incidence of Turner syndrome compared to the gen-
eral population.11 Falcon et al. in the study failed to
prove that the measurement of the gestational sac vol-
ume (GSV) at 11 to 13+6 weeks of gestation is a good
screening tool for detection of chromosomal defects.12
In trisomy-13 and triploidy the small GSV may be due
to early onset of fetal growth restriction and reduced
amniotic fluid volume. In trisomy-18 the increase of
GSV is probably due to the presence of associated fetal
abnormalities which interfere with impaired fetal swal-
lowing.12
The statistical analysis shows that the majority of the
girls (approximately 85%) with monosomy X have mar-
kedly increased NT in the first trimester, compared with
trisomy-21 cases where increase of NT is not so strik-
ing.13,14 In trisomy-21 the NT increases on average 2 mm
above the normal value, while in monosomy X it in-
creases 7 mm above the normal value. Besides that, the
first trimester hypoechogenic nuchal region in fetuses
with Turner syndrome, often persist in the second tri-
mester as cystic hygroma.
Fetal tachycardia, occasionally observed in the first
trimester in fetuses with Turner syndrome, is the conse-
quence of delayed maturation of parasympathetic sys-
tem, can cause fetal heart failure.15
Intrauterine growth restriction (IUGR) in the first tri-
mester of fetuses with Turner syndrome is moderate,
and, according to some studies, insignificant.14,16
Bronstein et al. studied 40123 consecutive pregnant
women at 14 to 16 weeks of gestation, with fetal karyo-
typing performed in 9348.17 Turner syndrome was de-
tected in 13 fetuses (0.03%, 1/3086 of early pregnan-
cies).17 Huge septated cystic hygroma, severe subcuta-
neous edema, and hydrops were observed in all cases.17
Short femur was detected in 12 out of 13 fetuses.17 A
narrow aortic arch was visualized in all 8 fetuses scan-
ned after 1995, when scanning of the aortic arch became
mandatory in their institution.17 Four other fetuses had
three or four of the five markers, 2 of the fetuses had
trisomy-21, 1 fetus was normal, and one case of missed
abortion occurred in a fetus in whom karyotyping was
not performed.17 They concluded that a reliable diagno-
sis of Turner syndrome by ultrasound is possible in early
pregnancy.17
The »second trimester« ultrasound
(18 – 23 weeks)
The fetuses with 45,XO Turner syndrome develop in
the second trimester severe lymphatic abnormalities vis-
ible by ultrasound. The most typical almost characteris-
tic sign is septated cystic hygroma (Figures 3 and 4). Of
the fetuses with cystic hygroma 75% have chromosomal




Slika 3. Cisti~ni higrom s pregradama u ploda s Turnerovim sindromom u
drugom tromjese~ju trudno}e
Figure 2. Cystic hygroma in fetus with Turner syndrome. 3D view with
clearly depicted septum
Slika 2. Cisti~ni higrom vrata u ploda s Turnerovim sindromom. 3D
prikaz jasno vidljivog septuma
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abnormalities, and over 95% of them having Turner
syndrome.18 Other echographic findings usually found
in Turner syndrome in the second trimester include:
lymphedema of the limbs, hydrotorax and ascites (Fig-
ure 5). The intrauterine death is usually caused by fetal
hydrops with characteristic ultrasound finding resem-
bling space suit (Figures 6, 7 and 8).
Turner syndrome is also associated with other abnor-
malities visible on the ultrasound like: cardiac abnor-
malities, especially of the left heart (coarctation of the
aorta, defects of the aortic valve); renal abnormalities;
skeletal dysplasia (shorten of the femoral bone), and
some unspecific minor defects. All ultrasound signs pre-
senting in fetuses with Turner syndrome (»sonographic
syndrome«) in the second trimester are more suggestive
for the diagnosis than in other aneuploidies (especially
in Down syndrome) (Figures 9 and 10). This is the rea-
son why some authors believe that the diagnosis of
Turner syndrome can rely on ultrasonic findings alone
which is not the case in the diagnosis of Down syn-
drome.17 Whenever major anomalies are identified by
ultrasound, even if they are isolated as in the case of se-
vere hydrops, then karyotyping is indicated.
So called »sonographic syndrome« in the second tri-
mester is also present in fetuses with triploidy. Ultra-
sound findings in triploidy include minor facial anoma-
lies, facial asymmetry, low set ears, mild ventriculo-
megaly, multiple major structural defects of the internal
organs, IUGR (asymmetric most frequently), oligohy-
dramnios, placental abnormalities, cyst of the posterior
fossa and syndactily (most frequently of the third and
the fourth finger). Other possible ultrasound findings in
triploidy are: hypertelorism and microphtalmos, micro-
Figure 4. Cystic hygroma in the hydropic fetus after abortion at 19 weeks
Slika 4. Cisti~ni higrom u poba~enog hidropi~nog ploda od 19 tjedana
Lungs = plu}a; Heart = srce; Hydrothorax = hidrotoraks
Figure 5. Ultrasound of fetus with hydrothorax at 22 weeks of gestation
Slika 5. Ultrazvuk ploda s hidrotoraksom nakon 22. tjedna trudno}e
Figure 6. 3D ultrasound of hydropic fetus with ascites and hydrothorax at
22 weeks of gestation
Slika 6. 3D ultrazvu~ni prikaz hidropi~nog ploda s ascitesom i hidro-
toraksom nakon 22. tjedna trudno}e
Figure 7. Cystic hygroma in fetus with Turner syndrome at 18 weeks of
gestation
Slika 7. Cisti~ni higrom u ploda od 18 tjedana s Turnerovim sindromom
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gnatia, major facial anomalies (cleft), agenesis of corpus
callosum, cardiac malformations, single umbilical ar-
tery, omphalocele, renal anomalies (Figures 11 and 12).
Jauniaux et al. investigated the role of ultrasono-
graphy and maternal serum human chorionic gonadotro-
pin in the early prenatal diagnosis of triploid pregnan-
cies.8 There were 18 cases of triploidy identified in the
population of 58 862 singleton pregnancies giving a
prevalence of 1 in 3270. Fetal defects were observed in 8
(44.4%) of these cases: holoprosencephaly in 4, exo-
mphalos in 3, and posterior fossa cyst in 1. In 6 (33.3%)
pregnancies the placenta showed molar changes. Fetal
crown-rump length was below the 5th percentile in 10
out of the 16 (62.5%) cases for which the menstrual age
was also available. Fetal nuchal translucency thickness
was above the 95th percentile in 12 (66.7%) fetuses, and
the fetal heart rate was below the 5th percentile in 4 out of
the 13 (30.8%) examinees. The maternal human chori-
onic gonadotropin level was high in 11 out of the 13
(84.6%) cases, with similar distribution of the high val-
ues in molar and nonmolar triploidies. They concluded
that the combination of ultrasonographic examination of
the fetoplacental features and measurement of the ma-
ternal serum level of human chorionic gonadotropin en-
able the diagnosis of triploidy at 10 to 14 gestational
weeks in the majority of affected fetuses.8
Specific prenatal diagnosis
of the Turner syndrome and perspectives
for the direct non-invasive prenatal
diagnosis of the chromosomal defects
The ultrasonically suspected diagnosis of monosomy
X is confirmed by determination of karyotype of fetal
cells obtained by amniocentesis or chorionic villi sam-
pling of the product of conception in high risk pregnan-
cies. The risk for miscarriage is 0,5% after chorionic
villi sampling and amniocentesis in general, while it is
5% for early amniocentesis. To increase the detection
rate and to decrease the loss of normal products of con-
ception with optimal cost/benefit ratio, 5% of pregnan-
cies with the highest genetic risk found by prenatal
screening should be investigated invasively.
Figure 8. Image of aborted fetus with Turner syndrome
at 18 weeks of gestation
Slika 8. Prikaz poba~enog ploda s Turnerovim sindromom
nakon 18 tjedana trudno}e
Figure 9. Sonographic markers of Turner syndrome
in a fetus at 17 weeks of gestation
Slika 9. Ultrazvu~ni biljezi Turnerova syndrome u ploda
sa 17 tjedana
a: short femur below the 5
th
percentile – kratak femur
ispod 5. percentile; b: cystic hygroma – cisti~ni higrom;
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The risk of invasive procedures for prenatal diagnosis
of fetal chromosomopathies is considered unacceptably
high, which prompt the investigators to search for non-
invasive methods of fetal genetic diagnosis. DNA anal-
ysis of fetal cells from maternal blood might be theore-
tically performed by fluorescent in situ hybridization
(FISH). It is necessary to concentrate fetal cells from
maternal blood from 10–5, to at least 10–2, which can be
experimentally done by magnetic or fluorescent acti-
vated cell sorting (MACS, respectively FACS) enabling
separation of acceptable number of fetal cells from ma-
ternal blood for the analysis. Analysis of free fetal DNA
from the maternal blood seems to be easier than the
molecular genetic analysis of fetal cells. For the diagno-
sis of aneuploidy the quantitative analysis of free fetal
DNA from maternal blood seems to be sufficient, as it
was proved that free fetal DNA is significantly de-
creased in Turner syndrome and significantly increased
in trisomies, compared with normal pregnancy.
Clinical aspects
From the point of view of the general practitioner and
pediatrician, the diagnosis of Turner syndrome is usu-
ally simple, because of very suggestive phenotype of the
female patients. Although some usual symptoms could
be absent, if the female patients are presenting at pu-
berty for the lack of onset of the secondary sexual char-
acteristics, primary amenorrhea or even secondary ame-
norrhea, than Turner syndrome should be suspected.
From the obstetrician’s point of view, prenatal diagnosis
of Turner syndrome is not so obvious and simple. The
management of the pregnancy with affected fetus may
create problems in practice, which should be solved in a
tertiary perinatal center.
Triploidy syndrome is characterized by general dys-
maturity, muscular hypotonia, large posterior fontanel-
le, low set dysmorphic auricles, hypertelorism, micro-
phthalmia and coloboma, cutaneous syndactily of the
third and the fourth finger, simian crease, micrognathia,
major facial anomalies (cleft), holoprosencephly, age-
nesis of the corpus callosum, cardiac malformations,
omphalocele, renal hypoplasia and other anomalies, hy-
pospadias and/or maldeveloped external genitalia.20
There were several studies presenting detection of
structural fetal abnormalities in the first trimester by ul-
trasound. Malone and al.21 studied prevalence, natural
history, and outcome of septated cystic hygroma in the
first trimester of the general obstetric population, in or-
der to differentiate this finding from the simple in-
creased nuchal translucency. There were 134 cases of
cystic hygroma (2 lost to follow-up) among 38 167
screened patients (1 in 285). Chromosomal abnormali-
Figure 10. Appearance of aborted fetus from the Figure 9 with hydrops,
cystic hygroma and morphological changes of the face
Slika 10. Izgled ploda sa slike 9 koji ima hidrops, cisti~ni higrom i
morfolo{ke promjene na licu
Figure 11. Fetus with triploidy at 22 weeks of gestation. Typical depiction
of single umbilical artery
Slika 11. Plod gestacijske dobi od 22 tjedna s triploidijom. Vidljiva je
jedna pup~ana arterija
Figure 12. Appearance of aborted fetus with triploidy.
Hypertelorism, microphtalmos, micrognathia, facial




finger of the left hand should be noticed
Slika 12. Izgled ploda s triploidijom nakon poba~aja.
Vidljive su sljede}e malformacije: hipertelorizam,
mikroftalmija, mikrognatija, asimetrija lica, nisko polo`ene
u{ke, sindaktilija 3. i 4. prsta na lijevoj {aci
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ties were diagnosed in 67 (51%), including 25 triso-
my-21, 19 Turner syndrome, 13 trisomy-18, and 10 oth-
ers. Major structural fetal malformations (primarily car-
diac and skeletal) were diagnosed in 22 of the remaining
65 cases (34%). There were 5 cases (8%) of fetal deaths
and 15 cases of elective pregnancy termination without
evidence of abnormality. Their opinion was that the first
trimester cystic hygroma was a frequent finding in a
general obstetric screening population. It has the stron-
gest prenatal association with aneuploidy described to
date, with significantly poorer outcome compared with
simple increased nuchal translucency. Most pregnancies
with normal evaluation at the completion of the second
trimester resulted in a healthy infant with a normal pedi-
atric outcome.21
The primary defect in the formation of the lymphatic
vessels is a part of a larger phenomenon of the cell mi-
gration in embryogenesis and it seems to determine
many defects including cardiovascular,22 which are de-
scribed in the syndrome. Fetal tachycardia seems to be
caused by the delay in the maturation of the parasympa-
thetic system, which resulted with the lack of the physi-
ological decrease in the heart rate after 9 weeks.15
In the newborn, the consequences of the defects in the
formation of the lymphatic vessels are clinically rele-
vant, presenting as:
– Lymphedema, generalized or localized on the dor-
sal part of the hands and feet;
– Pterygium colli (webbed neck), as a result of the re-
sorption of the cystic hygroma from the intraute-
rine life; in 40% of the cases, the neck is short, with
hypoplasia of the cervical vertebre;
– Distortion and characteristically low set ears;
– Distortion of the nails in 70% of the cases.
The eponym Bonnevie–Ullrich refers to the cases
with lymphedema of the extremities, significant nuchal
fold and pleural effusion/ascites/pericardial effusion,
which resolve spontaneously.
In girls with Turner syndrome, the following observa-
tions can be found:
– Low stature with impaired relation between height
and weight. Normal levels of GH and IGF1 in the
childhood could be found. The improper somatic
development is one of the definitive phenotypic
characteristics of the female patients with Turner
syndrome correlating with 45,XO karyotype, prac-
tically present in 100% of these patients. If in the
first years of life in the patient with Turner syn-
drome the levels of GH and IGF1 are normal, from
the age of 8 to 10 years it is decreasing probably
due to the lack of estrogens to induce the normal
dynamics of the puberty;23
– Skeletal deformations: scoliosis, cubitus valgus,
shortening of the 4th and the 5th metacarpal bone,
high arched palate;
– Characteristic aspect of the face, with low set ears,
low posterior hairline, thick eyebrows, micrognathia;
– Pectus excavatum with widely spaced nipples;
– Loss of hearing with progressive neuro-sensorial
impairment, recurrent otitis media, defects in the
formation of the temporal bone and of the syn-
chondrosis between the sphenoid and the occipital
bones, which lead to the abnormal positioning of the
external hearing meatus and of the middle ear;
– Lack of initiation or slowly initiating puberty, pri-
mary amenorrhea, or even secondary amenorrhea
in the patients in whom the primordial follicles re-
main undeveloped until the adolescence (rarely oc-
curring in the 45,XO patients). 5–10% of the fe-
male patients with gonadal dysgenesis with 45,XO
karyotype have in adolescence enough undevel-
oped ovarian follicles (approximately 10000) to
Table 2. Ultrasound findings in triploidy (adapted from reference
19
)















Number of fetuses – Broj plodova 70 17 20 4444 151
Increased NT/hygroma – Pro{iren nuhalni nabor/higrom 11% – 5% 7% 9%
Holoprosencephaly – Holoprozencefalija 3% – – 4% 3%
Ventriculomegaly – Ventrikulomegalija 34% 23% 25% 21% 23%
Facial cleft – Rascjep lica 1% – – 2% 1%
Micrognatia – Mikrognatija 24% – – – 24%
Abnormal limbs – Nakaznosti okrajina 49% – 5% – 38%
Abdominal wall defect – Defekti trbu{ne stjenke 6% 12% 0 4% 5%
Central nervous system abnormality
Nakaznosti sredi{njeg `iv~anog sustava
29% 41% 45% 30% 35%
Cardiac defect – Sr~ane gre{ke 31% 6% 5% 11% 20%
Intrauterine growth restriction – Intrauterini zastoj rasta – 71% 55% 32% 44%
Urinary tract anomaly – Nakaznosti mokra}noga sustava 11% 23% 15% 7% 13%
Myelomeningocoele – Mijelomeningocela 7% 25% – 9%
Oligohydramnios – Oligohidramnij 44% 59% 60% – 50%
Posterior fossa anomaly – Nakaznosti stra`nje lubanjske jame 7% 12% 0 – 7%
>1 anomaly – >1 nakaznosti 100% 94% 85% 79% 92%
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initiate the development of the breast and, less fre-
quently, the menstruation;
– The cardiovascular disorders represent the major
morbidity influencing prognosis in the patients
with Turner syndrome. The cardiovascular defects
resulting from the defective formation of the lym-
phatic system are present in almost 30% of these fe-
male patients. The left heart is most frequently af-
fected, presenting as coarctation of the aorta (pres-
ent in 10% of 45,XO patients), aortic valve defects,
aortic valve atresia. Aortic dissection, which devel-
ops in relation to the coarctation or other defects in
the formation of the aorta, is a well-known cause of
death in Turner syndrome. Over 30% of the female
patients with Turner syndrome, regardless of the
age, have moderate arterial hypertension;
– Renal abnormalities, although present in more than
one third of the female patients with Turner syn-
drome, have limited clinical relevance because
they usually do not significantly influence the renal
function;
– The cognitive function is generally normal in the
female patients with Turner syndrome.
Pathophysiology
45,XO karyotype may theoretically result from non-
disjunction in the meiosis in one of the parental ga-
metogenetic lines, but it is possible to result from a mito-
sis defect i.e. the loss of a chromosome either during the
germinal cell mitoses in the parental gametogenetic
lines or between fertilization and the first mitotic divi-
sion of the cells in the newly formed organism. It seems
that these errors in the cellular division appear more fre-
quently when one of the parental sexual chromosomes is
abnormal. The chromosomal defect would determine
the cellular division defect. At the first mitotic division,
the phenomenon of the delay in anaphase (anaphase lag)
may result in the loss of a sexual chromosome (which
may be abnormal). The loss of the abnormal sexual
chromosome is a phenomenon which may appear in the
prenatal as well as in the postnatal period.
The hypothesis of the mitotic error involved in the on-
set of Turner syndrome is supported by clinical observa-
tions:
– Sporadic occurrence of the phenomenon, regard-
less of the maternal age (unlike Down syndrome or
Klinefelter syndrome);
– High percentage of mosaicism cases;
– Existence of monozygotic twin pregnancies with
45,XO of one fetus and 46,XY of the other fetus.
The incidence of subjects with genetic mosaicism is
dependent on the used analytical method. It ranges from
30–40% when conventional karyotyping techniques
were used, or up to 75% when PCR amplification and in
situ hybridization with specific Y probes were applied.24
According to the recent investigations extremely high
rate of in utero mortality of products of conception with
pure 45,XO karyotype raised hypothesis that all survi-
vors with Turner syndrome have mosaicism. The hy-
pothesis that all subjects with Turner syndrome, who
survive till term have, at least initially, mosaic karyo-
type is supported by the following considerations:
– The existence of euploid cellular line in fetal mem-
branes where selective imprinting phenomenon of
the both sexual chromosomes takes place is re-
quired.
– The fact that at birth in most girls with Turner syn-
drome variable number of undegenerated follicles
can be found, which means that two active X chro-
mosomes were present to maintain the gameto-
genetic line.
Familial cytogenetic studies showed more frequent
loss of X chromosome of paternal than maternal origin.
It seems that in over 2/3 of the patients with Turner syn-
drome paternal X chromosome is lost, which is hard to
explain. Although the influence of the specific imprint-
ing of the remained X chromosome on the Turner phe-
notype was proved, it was not possible to demonstrate
the advantage concerning the survival of the product of
conception with X chromosome of maternal origin.25
The identification and localization of the genes on X
chromosome (»Turner genes«), whose haploid insuffi-
ciency leads to the Turner phenotype, started from the
idea that these genes should exist also on the Y chromo-
some.26 The most logical localization for these genes
would be the pseudo-autosomal region of the short arms
of the sex chromosomes, because it is the region partici-
pating in the crossing-over of the sex chromosomes dur-
ing meiosis, and where most of the genes are not af-
fected by the X-inactivation phenomenon. The cyto-
genetic study of the subjects with the karyotype 46,XYp
revealed lack of the testicular determination factor SRY,
which is the reason why they develop female phenotype,
either with normal height or with Turner-like pheno-
type, depending on the additional deletions on Y chro-
mosome. This fact enabled identification of a 700 kb
segment in the pseudo-autosomal region at the end of
the short arms of the sex chromosomes. The gene situ-
ated in this region, whose haploid insufficiency would
determine the short stature in Turner syndrome, is
known as short stature homeobox – gene on X chromo-
some (SHOX). Despite the fact that SHOX is involved
in chondrogenesis, the lack of one of two active copies
of the gene normally found in the cells of the normal in-
dividual, are (partially) responsible for the short stature
in the female patients with Turner syndrome.
SHOX is just one of the »Turner genes« responsible
for Turner phenotype which is determined by multiple
factors. According to Ogata and Matsuo27 there are at
least three factors involved in the development of clini-
cal features in Turner syndrome:
– Quantitative loss or impairment of the euchromatin
from extensive regions of the X chromosome (up to
the absence of the entire chromosome), with global
and unspecific developmental deficiency of the or-
ganism;
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– Haploid insufficiency of the growth pseudo-au-
tosomal genes, normally active on both sex chro-
mosomes and of the lymphogenic genes, with the
appearance of the growth retardation and other
»Turner marks«;
– Defective coupling of the sex chromosomes in the
prophase of the first meiosis, with loss of the ga-
metogenetic line and gonadal dysgenesis.
Three different mechanisms may produce triploidy:
1) nondisjunction in the first or in the second meiosis of
spermatogenesis, resulting in an extra set of paternal
chromosomes (diandry); 2) nondisjunction in the first or
in the second meiosis of oogenesis, resulting in an extra
set of maternal chromosomes (digyny); 3) double fertil-
ization of a normal egg, resulting in an extra set of pater-
nal chromosomes (dispermy).
The first mechanism accounts for 23,6% of triploidy
cases, the second mechanism accounts for 10%, and the
third mechanism for 66.4% of triploidy patients.28 Type
I (diandry) triploid pregnancy presents with large pla-
centa, partial molar changes, severe symmetric growth
restriction, elevated levels of maternal hCG, AFP, in-
hibin A, and rarely survives beyond the first trimester.
Type II (digyny) pregnancy has a small placenta, asym-
metric growth restriction, decreased levels of maternal
hCG, AFP, inhibin A, and more often survives till the
second trimester and eventually near term. No matter
that incidence of digyny is decreased compared to
diandry, it is more important for the diagnosis by ultra-
sound.
Defects of lymphogenesis in Turner syndrome de-
velop due to the deficiency of the receptor for vascular
endothelial derived growth factor 3 (VEGFR-3), protein
whose production is controlled by the gene on X chro-
mosome. The gene controlling production of BMX tyro-
sine-kinase enzyme involved in the mediation of the
VEGF effects at intracellular level, whose deficiency
affects early embryonic development, is also placed on
the X chromosome. Turner syndrome is also character-
ized by defect of the great lymphatic vessel formation.
Malformed lymphatic vessels are dilated due to the lack
of their communication with the veins. Lymphatic ves-
sel dilatation and intra-thoracic compression seem to de-
termine the entire range of cardiovascular and other de-
fects of the head and upper extremities described in the
syndrome.
Gonadal dysgenesis in Turner syndrome is due to the
fact that both X active chromosomes are required for the
formation and maintaining of the gametogenetic line.
Genes from both arms of the X chromosomes are in-
volved in normal ovarian development. Primary germi-
nal cells reach the gonadal ridge, but after the third
month of gestation, the oocytes and the primordial folli-
cles suffer an accelerated process of atresia, probably
due to the impossibility to correctly perform the pro-
phase of the first meiosis. Therefore, the ovaries un-
dergo a fibro-connective degeneration resulting in their
transformation into gonadal streaks. The fact that the
gonadal dysgenesis is caused by the accelerated atresia
and not by the abnormal formation in the germinal cells
was documented in the first studies about Turner syn-
drome. More recent studies show that in many cases this
process of atresia is not that fast to be complete at birth,
because almost one third of newborn girls with Turner
syndrome have at birth ovaries which are visible on ul-
trasound with undegenerated follicles. These follicles
may persist until after the puberty, determining the onset
of the secondary sexual features, menarche and even
fertility in the female patients with Turner syndrome.
There is inter-individual variability of the speed of fol-
licular atresia probably dependent on the specific X
chromosome defect. The spontaneous onset of pregnan-
cies in female patients with Turner syndrome can be ex-
plained by mosaicism or by the non-disjunction mitosis
of germinal 45,XO cells, with the formation of 46,XX
oocytes. The women with 45,XO cell lines have a higher
rate of spontaneous abortions and children with chromo-
somal abnormalities, than the general population.
The consequences of the deletions of X chromosome
are very variable providing to death in utero or to normal
female phenotype, with menarche and even fertility,
with the possibility of development of the secondary
amenorrhea. The incidence of the mosaic karyotype
with 45,XO lines in women with normal menstruation
and fertility is unknown. The understanding of the phe-
notypic consequences of the genotypic abnormalities in
Turner syndrome is the subject of detailed recent stud-
ies.29
Because of the high death rate in the embryonic and
fetal period, the majority of the Turner syndrome cases
are diagnosed in the prenatal period. The prenatal diag-
nosis of the live fetuses with Turner syndrome, as well
as the prenatal diagnosis of the non-lethal chromosomal
defects in general, is important from social, ethical,
medical and economical point of view.
Conclusions
The importance of a correct diagnosis for any child, in
particular for families who are faced with »dysmorphic«
baby, and who are planning to have further healthy chil-
dren, cannot be overemphasized. According to our ex-
perience, pregnancies with malformed fetuses in our in-
stitution were terminated on time, and the families were
correctly counceled that there is no recurrence risk of
triploidy in the next pregnancy. This approach enabled
parents to plan their next pregnancy after appropriate
counseling provided by general practitioner and pedia-
trician. Pregnancies having the fetus with Turner syn-
drome are characterized by very high rate of in utero fe-
tal mortality and spontaneous abortions. More than 99%
of the pregnancies with conceptive product of concep-
tion with 45,XO karyotype have such fatal outcome.
In fetuses with ultrasonographically proved defects of
the lymphatic circulation in the early pregnancy and/or
intrauterine growth restriction associated with cardio-
vascular, renal or complex malformations later in preg-
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nancy, Turner syndrome should be suspected. Ultra-
sound examination in Turner syndrome showes: increa-
sed NT at the end of the first trimester, cystic hygroma or
even severe generalized lymphedema, moderate growth
retardation and fetal tachycardia later in pregnancy. Al-
most all fetuses with Turner syndrome have septated
cystic hygroma and hydrops, but not all fetuses with
cystic hygroma and hydrops are Turners.
As a conclusion both triploidy and Turner syndrome
must be taken in consideration if minor or major abnor-
malities in the first or in the second trimester of preg-
nancy are revealed on ultrasound. Active screening in
the general population should be focused on the detec-
tion of all congenital anomalies and it is not justified for
only these two conditions.
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